Benchmark analyst Bruce Jackson reiterates Beauty Health (NASDAQ:SKIN) with a Buy and maintains $23 price target.
Benchmark Reiterates Buy on Beauty Health, Maintains $23 Price Target
Benchmark analyst Bruce Jackson reiterates Beauty Health (NASDAQ:SKIN) with a Buy and maintains $23 price target.
Related Posts
Evercore ISI Group Initiates Coverage On Integral Ad Science with Outperform Rating, Announces Price Target of $23
Evercore ISI Group analyst Mark Mahaney initiates coverage on Integral Ad Science (NASDAQ:IAS) with a Outperform rating and announces Price Target of $23.
Altamira Therapeutics Provides Business Update; Company Is Striving To Sell Or Partner Its Other Legacy Assets, Inner Ear Therapeutics; Agreed Upon Sale Assets To The European Family Office Did Not Close As The Buyer Was Not Able To Secure Financing
Similarly, the Company is striving to sell or partner its other legacy assets – inner ear therapeutics. Unfortunately, the agreed upon sale of these assets to a European family office (the "Buyer") did
Sugarbud Upsizes Its Marketed Public Offering Of Secured Convertible Debenture Units
Sugarbud Craft Growers Corp. (OTCQB: SBUDF) has agreed to amend the terms of its previously announced $2.4 million marketed